Investors

Conduction of IPO has been planned with further entry to the Hong Kong Stock Exchange by 2020.

We guarantee our partners:

  • Prompt establishment of modern high-tech drug production, equipped with international standards;
  • High quality products that underwent three-factor verification before sales launch;
  • Equally fast delivery for both large and small lots of products;
  • Convenient individual conditions of cooperation;

We invite you to become our partner!

Investors
Name Koru Pharmaceuticals Co., Ltd
Revenues in 2016 7 million USD
Revenues in 2017 15 million USD
Staff 80 employees
Work geography Over 40 countries
Number of labs 3
Number of suppliers 220
Number of products Over 300

Contact us

Apply now and our manager will get in touch with you shortly.
* — must be filled in.

On details regarding investment, you can also contact us at the following address: finance@korupharma.com